Molecular Diagnostics Companies 2018

IVD Market Overview: The global in vitro diagnostics market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4. 4% over the forecast period. Compare HTG Molecular Diagnostics to its competitors by revenue, employee growth and other metrics at Craft. Diagnostic Genetic Services and Genetic Counseling. Oct 24 | Diagnostics World News | The world of medicine is continually seeking new methods to improve health outcomes through a variety of innovative mechanisms, and accelerated diagnostics is no exception. With molecular diagnostics to biomarker-based personalised therapy. Application of biomarkers in molecular diagnostic is increasing, due to advantages of biomarkers such as aiding in early detection of specific diseases. The poc molecular diagnostics Market Research Report provides market size, share, growth, trends, demand, forecast and company profiles. 9 million as of 2016 and is expected to reach $ 6980 million in 2026 with an average annual growth rate of 32. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE. MarketExpertz offers wide collection of premium market research reports. Molecular Diagnostics to Aid Hologic's (HOLX) Q3. Salary, bonuses, stock options, stock awards and other compensation for John L. IVD Market Top 25 Companies: Revenue Performance, Products, Competitive Activity IVD Market Top 25 Companies presents advancements in in vitro diagnostics (IVD) by the Top 25 firms in the industry and provides an overview of the most recent trends and developments. 76 Bn by 2026, at a CAGR of 18. Codexis’ proven technology enables implementation of biocatalytic. A thorough yet succinct guide to using molecular testing technology, Principles and Applications of Molecular Diagnostics is an essential resource for laboratory professionals, biologists, chemists, pharmaceutical and biotech researchers, and manufacturers of molecular diagnostics kits and instruments. applications of molecular science *Clinical Laboratory Standards Institute (CLSI) publishes discipline-specific application guidelines in the area of Molecular Methods. Identify emerging trends and strategies in cancer genomics and molecular diagnostics that can be used to monitor clinical efficacy of treatment and improve patient outcomes ; Faculty. Market Trends and Outlook. Interview with Attila Lorincz by Claire Raison (Commissioning Editor) To mark the beginning of the 15th year of Expert Review of Molecular Diagnostics, the journal's Editor-in-Chief shares his. ALAMEDA, Calif. 35 million by 2024, while witnessing a CAGR of 9. The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets. HTG Molecular Diagnostics, Inc. Molecular diagnostics includes the molecular biology techniques that are used for the detection of biomarkers present in genomes or proteomes. (HTGM) News – Find the latest company news headlines for HTG Molecular Diagnostics, Inc. United States Molecular Diagnostics Systems Market Report 2018 1 Molecular Diagnostics Systems Overview 1. The report will assist the reader with a better understanding and decision making. com February 08, 2018 06:01 AM Eastern Standard Time. Molecular diagnostics is an essential part of clinical laboratory. 71 Billion in 2018, at CAGR of 8. Company was founded in 2016 and is headquartered at the JLABS facility in San Diego, CA. Rise in the expenditure on diagnostics, therapeutics, feed additives, and other supplies for companion animals; increase in the number of pet owners and growing urbanization are likely to provide significant opportunities to the veterinary molecular diagnostics market in developing countries during the forecast period. 4% over the forecast period. Molecular Diagnostics Update. How much did John L. A companion diagnostic device can be in vitro diagnostic device or an imaging tool that provides information that is essential for the safe and effective use of a corresponding therapeutic product. the Company towards the significant opportunity we see in molecular diagnostics. Utilizing advanced genomic technologies and bioinformatics analysis, Admera Health delivers cost-effective clinical diagnostics spanning the continuum of care from its established, CAP-accredited laboratory. The Registered Agent on file for this company is The Corporation Trust Incorporated and is located at 2450 York Rd Suite 201, Lutherville Timonium, MD 21093. 88 billion by 2025. Table of Contents for United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies by Renub Research. (C2294569). Table 30: World 14-Year Perspective for Molecular Diagnostics in Infectious Disease Testing by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart). Search Molecular diagnostics jobs. The company was formerly known as HTG, Inc. 4% over the forecast period. develops and markets a technology platform to facilitate the routine use of complex molecular profiling. Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies - The global molecular diagnostics market is witnessing a period of profound growth. 9 million as of 2016 and is expected to reach $ 6980 million in 2026 with an average annual growth rate of 32. Codexis, Inc. Codexis appoints Senior Director of Molecular Diagnostics. Molecular Diagnostics Market fuelled by the growing prevalence of infectious diseases & cancers, rising awareness and acceptance of personalized medicines, increase in the biomarker identification, and improvement in molecular diagnostics. HTG Molecular Diagnostics to Complete FDA Filing for Gene Assay HTG, a company that provides molecular profiling services, expects to complete submission of its premarket approval application to FDA for an in vitro gene assay by 2018. 9% from 2018 to 2025 to reach $12. A Utah corporation headquartered in Salt Lake City, Utah, we commercialize our innovative patented and patent-pending technology through sales, development and licensing, to quickly develop molecular diagnostics that are more cost-efficient and perform better. Our proprietary lab-on-chip ACE platform offers a rapid and affordable way to isolate nanoparticles directly from physiological solutions, such as whole blood, plasma or serum. The global Molecular Diagnostics in Cancer Testing market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. biz shares a report on Molecular Diagnostics in Infectious Disease Testing Market 2019 which provides the company profile, primary Research, capacity, Secondary Research, and market shares for each competitor. The US occupied a dominant market share, i. The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets. Molecular Diagnostics Technologist (MDT) Information Resource References Competency-based, criterion-referenced examinations are not based solely on textbook information, but on the skills and competencies required for safe and successful performance as a healthcare practitioner. At Interpace Diagnostics Group, we're providing personalized medicine through molecular diagnostics and innovation. (Nasdaq:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today reported financial results for the first quarter ended March 31, 2018. com February 08, 2018 06:01 AM Eastern Standard Time. Introduction and Historical Perspective. In charge of the sales and support organization in the whole EMEA region, the goal is to introduce new technologies in the diagnosis strategies of each country. Company was founded in 2016 and is headquartered at the JLABS facility in San Diego, CA. In Vitro Diagnostics Market Global Briefing 2018 Including: Molecular Diagnostics, Point-of-Care Diagnostics, Immunochemistry, Microbiology, Hematology and ImmunohematologyCovering: Siemens Healthineers, Abbott Laboratories Inc. Progenity, a San Diego molecular diagnostics company focused on women's health, reproductive medicine, and oncology, has raised $125 million in a Series B financing led by New York's Athyrium. Forecasts are made up to 2028. Molecular Diagnostics for Infectious Disease Improving Clinical Outcomes through Molecular Testing August 21-22, 2019. , a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial services for targeted cancer therapies, in collaboration with OncoMed Pharmaceuticals, Inc. ANGSANA MOLECULAR AND DIAGNOSTICS LABORATORY PTE. Cepheid's fully automated GeneXpert® systems enable rapid, sophisticated genetic testing and provide test results for the management of infectious diseases, among many clinical. genedrive plc and the Foundation for Innovation of New Diagnostics (FIND), announced today a s. 3B BlackBio Biotech offers a wide range of products and services in different fields of molecular testing. Key Tips for Diagnostics in 2018 and Beyond: Development Success in the Evolving US and EU Landscape Medical Device, Medical Device Clinical Trials, Medical Device Diagnostics, Medical Device Safety and Regulation, Thursday, December 14, 2017. Johnson , Executive Chairman and former Chief Executive Officer at HTG MOLECULAR DIAGNOSTICS. With a lineage of nearly 12 exclusive molecular diagnostics products, the company is making profound inroads in advanced gene sequencing cancer therapy. Resolve Molecular Diagnostics Limited Liability Company is a Maryland Foreign LLC filed on June 29, 2018. is a molecular diagnostics company with unique, patented Polymerase Chain Reaction ("PCR") testing technology. National Molecular Microbiology Diagnostics User Group (NMG) was formed in 2006 with the primary purpose of enhancing public health and laboratory services by networking and collaboration among clinical molecular diagnostic laboratories. Diagnostics (The Genedrive® Platform) Hepatitis C (HCV) Receipt of CE-IVD certification for our HCV ID Kit in September 2017 was a significant achievement for the Company, positioning us as the first to market with a. Directory of Bay Area and Northern CA Biotech Companies. , 32% in 2017, and is expected to grow at a CAGR of 8. Beaumont Health – Annual Symposium on Molecular Pathology. 2 billion by 2024. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). Initial assay development focus is on Sexually Transmitted Infections and Respiratory Tract Infections. company directory In Vitro Diagnostics Find your German partner About us Germany Trade & Invest (GTAI) is the economic development agency of the Federal Republic of Germany. QIAGEN is a world leader in genomic medicine and molecular diagnostics, with an existing research and development centre in Manchester. Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Product (2014-2018). In the current diagnostics market, molecular diagnostics for infectious disease testing offers one of the brightest areas for growth and innovation. ELITechGroup Molecular Diagnostics, ELITe InGenius (Molecular, 2018) No. A raft of players in the global molecular diagnostics market is entering into strategic partnerships with biotech firms to provide novel diagnostics solutions in order to enhance their visibility. The company’s shares closed on Friday at $3. NANO4 platform provides a colorimetric molecular diagnostic method based on gold nanoprobes that allow fast and specific identification of a DNA or RNA biomarker. 0% forecast in 3 Years n/a. The global Molecular Diagnostics Market was valued at USD 6. 2015;34(5):1005-1009. PapGene’s core technology uses innovative massively parallel sequencing (MPS) techniques invented by world-leading cancer researchers at Johns Hopkins University. 21, 2019 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets. After the successful 2017 event 'Biosensors, Biomarkers & Diagnostics - From Research to Commercialization' SELECTBIO presents to you "Biomarkers - From Research to Commercialization" in Bengaluru, India. The Company's HTG Edge. These systems are typically based on statistical or machine learning models, built upon clinical or corporate patient data. Saving Lives with Genomic Testing. in March 2011. Cepheid's fully automated GeneXpert® systems enable rapid, sophisticated genetic testing and provide test results for the management of infectious diseases, among many clinical. 9% between 2019 and 2025. Molecular diagnostic markets are analyzed for 2018 according to technologies, applications and geographical regions. The technology is moving faster than the market. 2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85. Striking tailwind in the molecular diagnostics reagent comes from rising application of immunoassays for the therapeutic evaluation of drugs for infectious diseases. It is used to identify DNA and RNA at molecular level. 8 billion by 2026,progressing at a CAGR of 9. Offerings include assays and automation for infectious disease, oncology, and genetics. Jeffrey Gregg, MD Senior Director, Clinical Pathology Director, Molecular Diagnostics Professor of Pathology Department of Pathology and Laboratory Medicine. engages in the provision of molecular technology solutions that facilitates molecular profiling. , April 03, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX) today announced the appointment of Ronald Andrews, Jr. 22-24 May 2018 Lisbon, Portugal Sheraton Lisboa Hotel & Spa 6th International Spread the word about your attendance at Molecular Diagnostics EUROPE 2018 in Lisbon, Portugal! EXHIBITOR MARKETING TOOLS: Here are a few items to help you get a head start on creating a buzz around your booth at #MDxEU18 this May. We put this company in the category Other according to its activity. Goffin Molecular Diagnostics Technologies is a leading company based in the Netherlands and specialized in molecular diagnostics technologies solutions. Carrera Bioscience is also a Contract Research Organization that performs Luminex platform testing for pharmaceutical companies and. Point of care testing eliminates the need for samples to be sent. For instance, in February 2018, the FDA granted marketing approval to Banyan Biomarkers, Inc. This report describes and evaluates the. Lucence Diagnostics Pte Ltd (UEN 201605840N) is licensed by the Ministry of Health (Singapore) as a Clinical Laboratory (License Number: 17I0039/02/182). The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical. Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies - The global molecular diagnostics market is witnessing a period of profound growth. HTG Molecular Diagnostics has an analyst consensus of Strong Buy, with a price target consensus of $4. She is responsible for growing and enhancing Advanced Diagnostics, an area of the business based on genetic and molecular diagnostics requiring special expertise or technology in the areas of women's health, neurology and oncology testing. Advanced Molecular Diagnostics Ltd is an active company incorporated on 19 April 2017 with the registered office located in Nottingham, Nottinghamshire. David is a business and financial professiona. Qiagen’s “Sample to Insight” mission aims to offer end-to-end solutions to clinical labs and life science companies. The 'Global and Chinese Molecular Diagnostics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Molecular Diagnostics industry with a focus on the Chinese market. What is HTG Molecular Diagnostics's current dividend yield, its reliability and sustainability? Dividend Yield vs Market company n/a market bottom 25% 1. 35 million by 2024, while witnessing a CAGR of 9. In the span of few years, molecular diagnostics has prospered from a non-existent market to a significant market. , April 03, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX) today announced the appointment of Ronald Andrews, Jr. Dublin, Feb. As of June 30, 2018, QIAGEN employed approximately 4,800 people in over 35 locations worldwide. 23% during the forecast period, 2019-2024. (C2294569). During 2018, significant further investments were made in menu expansion. Because of this, the market size of the molecular diagnostics market is quite large. Two Millennia of Inquiry Before the rise of Molecular Diagnostics in the 1980s, clinicians were limited to a generalized approach to diagnosing. liquid biopsy, CRISPR, AAV). 45 million in 2018, and is estimated to be valued at USD 13,340. , (HTG) and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene. DUBLIN--(BUSINESS WIRE)--The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets. (HTGM) News – Find the latest company news headlines for HTG Molecular Diagnostics, Inc. TUCSON, Ariz. This video is unavailable. 12 billion in 2016 and is projected to reach USD 12. , an executive with over 30 years' experience in the molecular diagnostics and genomics industries, to the Company's Board of Directors. , the company operates more than 35 offices in over 25 countries. The global molecular diagnostics market is the one which deals with the analysis of biological markers in genome and proteome. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. com's offering. 10 average price target. Automated molecular diagnostics system for targeted and syndromic on-demand testing Novodiag is an innovative molecular diagnostics solution for the detection of multiple or targeted pathogens in clinical samples. Directory of Diagnostics Companies. 60) on an earnings per share basis. 2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85. 45 million in 2018, and is estimated to be valued at USD 13,340. The factors that are playing a major role in the growth of molecular diagnostics market are a technological enhancement in molecular diagnostic kits, the rising expenditure on enhanced diagnostics, and the growth in R&D activities by manufacturers. Glassdoor has 2 Molecular Diagnostics Laboratories reviews submitted anonymously by Molecular Diagnostics Laboratories employees. A thorough yet succinct guide to using molecular testing technology, Principles and Applications of Molecular Diagnostics is an essential resource for laboratory professionals, biologists, chemists, pharmaceutical and biotech researchers, and manufacturers of molecular diagnostics kits and instruments. Qiagen's "Sample to Insight" mission aims to offer end-to-end solutions to clinical labs and life science companies. United States Molecular Diagnostics Systems Market Report 2018 1 Molecular Diagnostics Systems Overview 1. 23% during the forecast period, 2019. Bio-Rad Laboratories, Inc. molecular tests were introduced for determining genetic variations of drug response to the cancer drug, irinotecan, and the blood thinner, warfarin. in March 2011. With over 500,000 customers, Qiagen’s products are used in almost every molecular biology lab in the world. In this situation, some developers allow labs to run an entire molecular panel, but view only results for the candidate pathogens they believe are most likely to be causing. The order for 100 molecular diagnostic instruments has been paid in advance and takes the number of q16 instruments sold into the Asia Pacific region to more than 230 units. ROBO Global ranks Qiagen NV as the No 1 company in molecular diagnostics Senior research analyst Nina Deka says the Netherlands-based company has four new platforms to go after a $4 billion market. , a molecular diagnostic company focused on oncology, positions he has held since February 2017. Press Release Global Molecular Diagnostics Market (2018-2024) - A $20. Because of this, the market size of the molecular diagnostics market is quite large. To refresh your memory, those 10 were:. An overview of the global market for molecular diagnostics. Topic: molecular diagnostics. The North American molecular diagnostics market size was USD 3. 4% during the forecast period. Genetic tests and genome sequencing play a key role in these diagnoses. Dublin, March 26, 2018 (GLOBE NEWSWIRE) -- The "Global Molecular Diagnostics for Infectious Disease 2019 to 2023 - Markets, Strategies and Trends, Volume & Price Forecasts by Pathogen and by Country" report has been added to ResearchAndMarkets. Increasing prevalence of infectious diseases, such as human papillomavirus and influenza, is expected to be the primary force driving the market. 45 million in 2018, and is estimated to be valued at USD 13,340. Profile information for each company in 'The Top 200 Molecular Diagnostics Companies Worldwide' includes: - Company Contact Information - Address, Telephone and Fax Numbers, Email and Website. Today the Molecular Diagnostics industry is an exploding field with a current market size of approximately $8B. Apply to Development Associate, Processor, Senior Research Assistant and more!. Molecular diagnostics markets overlap with markets for non-molecular diagnostic technologies in the in vitro diagnostic market and are less well defined than those for pharmaceuticals. September 2018 • TBD Association of Clinical Microbiology – Southwestern Annual Meeting (SWACM) September 2018 • TBD. EAC predicts that the MDx market will grow from its 2013 global size of $4. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018. 1 POC Molecular Diagnostics Supply 9. Company Website (Date Joined) 23andMe, Inc. As stated in EAC's 2012 Molecular Diagnostics (MDx) report, MDx has emerged as one of the largest and fastest growing segments in the $54 billion IVD industry. The company unveiled fourth-quarter revenue of $7. com’s offering. Convergence of Molecular Diagnostics & Anatomic Pathology May 2, 2018 As molecular diagnostics and anatomic pathology become increasingly intertwined, successful labs will thoughtfully integrate AP and molecular workflows. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. HTG Molecular Diagnostics employs 107 workers across the globe. Molecular Diagnostics Reagent Market Size 2018-2028. ROBO Global ranks Qiagen NV as the No 1 company in molecular diagnostics Senior research analyst Nina Deka says the Netherlands-based company has four new platforms to go after a $4 billion market. HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics has a market capitalization of $51. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, announced today that it is set to join. (OTCBB:MCDG) and DiagnoCure Inc. Europe Molecular Diagnostics Market: Research Methodologies The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue and volume of molecular diagnostics systems in the near future. The market research firm also said it expects this segment to expand at a compound annual growth rate (CAGR) of 9. The worldwide market for molecular testing was $3. 7 percent between 2013 and 2018. Molecular diagnostics plays an important role in Reprogenetics and Oncology, which has attracted more attention from the public than ever before. Strength in the Panther system and increasing utilization of Aptima women's health assays will boost Hologic's (HOLX) molecular diagnostics in Q3. Laboratory Diagnostics Siemens Healthineers offers a broad spectrum of immunoassay, chemistry, hematology, molecular, and urinalysis testing systems, in conjunction with automation, informatics and services to serve the needs of laboratories of any size – today and tomorrow. 71 billion in 2018, at a CAGR of 8. With more than 50 offices in Germany and abroad. com's offering. After the successful 2017 event 'Biosensors, Biomarkers & Diagnostics - From Research to Commercialization' SELECTBIO presents to you "Biomarkers - From Research to Commercialization" in Bengaluru, India. Global Molecular Diagnostics Market. This event will provide members of the media access all main conference programs, short courses, symposia plus: Keynote Presentations; 200+ exhibitors in the Exhibit Hall. For instance, in February 2018, the FDA granted marketing approval to Banyan Biomarkers, Inc. , March 07, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. Company was founded in 2016 and is headquartered at the JLABS facility in San Diego, CA. Qiagen: The most ubiquitous company in molecular diagnostics. Borahm Kim, Hyeonah Lee, Saeam Shin, Saeam ShinEmail the author Saeam Shin, Seung-Tae Lee, Seung-Tae LeeEmail the author Seung-Tae Lee, Jong Rak Choi. This report includes the major drivers ofmolecular diagnostics devices and equipment, restraints, historic and forecasts data. Companies are focussing on to develop new molecular diagnostic tests, which may foster growth of the market. By product, the market has been segregated into reagents & kits, instruments, and services & software. 6% during forecasted period 2018 to 2023 - Exclusive forecast by Market Research Future. Advances in genomics will increase the use of advanced molecular tests. Watch Queue Queue. A range of real-time PCR kits for accurate simultaneous detection of infectious agents involved in respiratory diseases. 6% during forecasted period 2017-2023. Moderator: Search This Board: Last Post: 8/9/2018 4:23:14 PM - Followers: 35 - Board type: Free - Posts Today: 0. Bachelor of Science Degree. Keywords: Molecular diagnostics, Blood cancer, In vitro diagnostics, Market analysis Background Molecular diagnostics (MDx) is an assay that evaluates genes, metabolic functions, drug metabolism, and disease induction based on DNA, RNA, and proteins. With over 500,000 customers, Qiagen’s products are used in almost every molecular biology lab in the world. was incorporated in 1997 and is based in Tucson, Arizona. Table 30: World 14-Year Perspective for Molecular Diagnostics in Infectious Disease Testing by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart). In 2018, the global Oncology Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Europe is expected to hold the major market share over period 2018-2026. 10-Q Q3 2018 (Quarterly Report) (click for more detail) Short Volume; Market Date HURC – Hurco Companies, Inc. SACACE develops, manufactures and sells through distributors more than 140 complete kits for human, veterinary and food diagnostics. molecular endocrinology, molecular oncology, toxicology, personalized medicine and more. HTG Molecular Diagnostics, Inc. This report studies the Molecular Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics market by product type and applications/end industries. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. 10 average price target. Admera Health is a molecular diagnostics company focused on personalized medicine. As technologies evolve and new discoveries emerge, AMP remains the keystone of the molecular diagnostics community. The Company's HTG Edge. Molecular diagnostics is a tool to improve clinical outcomes and medical decisions. Borahm Kim, Hyeonah Lee, Saeam Shin, Saeam ShinEmail the author Saeam Shin, Seung-Tae Lee, Seung-Tae LeeEmail the author Seung-Tae Lee, Jong Rak Choi. Because it owns its platform, the company is able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services. Rise in the expenditure on diagnostics, therapeutics, feed additives, and other supplies for companion animals; increase in the number of pet owners and growing urbanization are likely to provide significant opportunities to the veterinary molecular diagnostics market in developing countries during the forecast period. , is an innovative Italian company founded in 2001 in order to operate in the field of biotechnology. See the complete profile on LinkedIn and discover usama’s connections and jobs at similar companies. These include next-generation sequencing, wearable sensors, liquid biopsies, direct-to-consumer testing, point-of-care assays, and early cancer detection. 2018, followed by full product roll out • Bacterial and Fungal human sepsis proof of concept phase 2 in late 2018. MC Diagnostics personnel have a wealth of experience in the design and development of molecular diagnostics applied to the fields of immunogenetics, immunology, blood banking and microbiology. 47 million and generates $21. Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH August 24, 2018 -- Bruker's MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections. biz delivers in-depth insights on the global molecular diagnostics market in its upcoming report titled, “Global Molecular Diagnostics Equipment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027”. Growing incidence of zoonotic and. Eur J Clin Microbiol Infect Dis. (MENAFN - GetNews) The global molecular diagnostics market is projected to reach USD 11. 4% market top 25% 3. The latest report on global Molecular Diagnostics Market added by Value Market Research present evidence-based information and covers all the market details such as the current technology trends, market opportunity analysis, and competitive landsc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Molecular diagnostic markets are analyzed for 2018 according to technologies, applications and geographical regions. (Nasdaq:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its. The Company's HTG Edge. Consolidated under the Dutch holding QIAGEN N. HOLX is slated to report third-quarter fiscal 2018 financial results on Jul 31, after the closing bell. HTG Molecular Diagnostics (HTGM) In a report released today, Mark Massaro from Canaccord Genuity maintained a Buy rating on HTG Molecular Diagnostics, with a price target of $6. is a single cell diagnostic company committed to advancing Precision Medicine by offering transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. , May 10, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. Clinical / Molecular Diagnostics Accessing Genomics for Better Human Health Advances in genetic analysis tools for molecular diagnostics are revolutionizing the practice of medicine, improving prenatal and reproductive care, enabling earlier disease detection, and advancing treatment of heritable disease. Head of Molecular Diagnostics Division - Life Technologies - Europe, Middle-East & Africa Life Technologies Januar 2011 – Dezember 2013 3 Jahre. While Asia Pacific region is considered as the fastest growing market in the forecasted period. Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. is the US headquartered company which develops, manufactures and market a wide range of products for molecular diagnostic and research. Roche, Abbott, Myriad Genetics, Qiagen and BioMérieux are some of the top companies operating in the Molecular Diagnostics; which has been studied thoroughly in the report. And the menu of products is much longer if we include. Blood cancer molecular diagnostics is usually performed based on platforms such as PCR. This research service analyes the revenue potential for molecular diagnostics market in major European countries like Germany, France, Italy, Spain, UK, Benelux,Scandianvia, Russia, Turkey, Poland and Czech Republic. 2% versus 2017, when the company's sales were SEK 23. Foundation Medicine. 1 billion in 2018, representing a compound. Molecular diagnostic markets are analyzed for 2018 according to technologies, applications and geographical regions. Global veterinary molecular diagnostics market expected to reach USD 736. Molecular Diagnostics to Aid Hologic's (HOLX) Q3. Oct 24 | Diagnostics World News | The world of medicine is continually seeking new methods to improve health outcomes through a variety of innovative mechanisms, and accelerated diagnostics is no exception. 4% during the forecast period 2018–2024. Our overall aim is to develop innovative methods for analysis and diagnostics within life science. Diasorin, The Diagnostic Specialist We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets. • Providing technical support to Hospital, Pharmaceutical industries and universities on molecular diagnostics equipment. NANO4 Platform relies on a colorimetric molecular diagnostic method based on gold nanoparticles that provide fast and specific identification of a DNA or RNA biomarker. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Advanced Molecular Diagnostics Ltd has been running for 2 years. If, at any time, you are interested in reverting to our default settings, please select Default. There aren't many sectors of industry that have seen the same amount of progress in the last 20 years as molecular diagnostics. Molecular diagnostics markets overlap with markets for non-molecular diagnostic technologies in the in vitro diagnostic market and are less well defined than those for pharmaceuticals. , the company operates more than 35 offices in over 25 countries. Clinical / Molecular Diagnostics Accessing Genomics for Better Human Health Advances in genetic analysis tools for molecular diagnostics are revolutionizing the practice of medicine, improving prenatal and reproductive care, enabling earlier disease detection, and advancing treatment of heritable disease. Molecular diagnostics is an essential part of clinical laboratory. engages in the provision of molecular technology solutions that facilitates molecular profiling. Diasorin, The Diagnostic Specialist We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. This report describes and evaluates the molecular diagnostics technologies that will play an important role in. 8th Aug 2018. Inflammatix, Inc is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. In July 2018, Biodesix, Inc. 97, close to its 52-week low of $2. Molecular diagnostics is a collection of techniques that are used to analyze biological markers in the genome and proteome. Molecular Diagnostics Reagent Market Size 2018-2028. Apply to Assistant, Data Entry Clerk, Recruiting Assistant and more!. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide. com's offering. For instance, in February 2018, the FDA granted marketing approval to Banyan Biomarkers, Inc. 6% during forecasted period 2017-2023. 7% during the forecast period 2018–2024. Molecular Diagnostics Group (MDG) is the company association of Biotype, qualitype and ROTOP Pharmaka, which combines expertise in molecular diagnostics, radiopharmaceutical theranostics, and bioinformatics. 66 billion in 2017 and is expected to register a CAGR of 10. The word on The Street in general, suggests a Strong Buy analyst consensus rating for HTG Molecular Diagnostics with a $7. Molecular diagnostics are used to diagnose disease and risk involved. 2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85. 21, 2019 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets. Faced with increased competition from other diagnostics companies, the client needed to develop a growth strategy that would strengthen its core franchise and help it expand into new disease segments. From this massive set of operations, because of our capabilities, we've developed about $1 billion of business in what we refer to as "advanced diagnostics," which as you mentioned centers on genetic and molecular testing—in fact, most people don't realize this, but we're the largest genetics diagnostic company out there right now. Acquired by: Anteo Diagnostics. USA - BPG: This is a Premium Listing. (US), Bio-Rad Laboratories(US), Beckman Coulter(US), Auto. With a lineage of nearly 12 exclusive molecular diagnostics products, the company is making profound inroads in advanced gene sequencing cancer therapy. PapGene, Inc. The Demand for Point-of-Care Diagnostics. In the current diagnostics market, molecular diagnostics for infectious disease testing offers one of the brightest areas for growth and innovation. H&m Molecular Diagnostics, LLC is a California Domestic Limited-Liability Company filed on January 29, 2018. With molecular diagnostics to biomarker-based personalised therapy. The North American molecular diagnostics market size was USD 3.